CROSSJECT : Une baleine sur X

GMendez

13 novembre 2025 •20:06

Intéressant ….
Des clichés … des video machine … Don Zin …
Étonnant….

Voxal

13 novembre 2025 •20:49

Gros portefeuille, 400kt accumulé en a peine 2 mois.

M7929284

13 novembre 2025 •21:47

Oui découvert il y a peu celui là, grosses bourses en effet !

crossjectwhale

17 novembre 2025 •09:40

:D

crossjectwhale

17 novembre 2025 •21:16

christ1341

13 novembre 2025 •19:48

Ça vaut ce que ça vaut, mais pour les intéressés, la page d'un "influenceur" avec une certaine visibilité :
https://x.com/cross ject

Hi all,
I go by the name crossjectwhale (x handle: @crossject) and I hold a bit over 400,000 shares. I’m not French and I am not from the medtech world. I found Crossject randomly through one comment on Twitter, which already says something about how little attention this company gets.

I wanted to share an outside view, without drama or complicated theory.

French small caps have a bad reputation because of the whole convertible debt culture. I knew that before buying. That is exactly why the recent Vatel financing caught my attention. The terms are cleaner, more balanced, and clearly better than older deals. It feels like Crossject finally negotiated from a healthier position instead of being forced into whatever was available.

ZENEO itself is the real reason I am here.
The technology solves a straightforward problem in emergency situations, military settings, and chemical or opioid response. It removes user error, it works instantly, and it fills a gap no other injector really covers. The support from BARDA and the French government is not symbolic. These organisations do not sign multi-year programs with companies that have nothing.

The world is unfortunately heading toward more instability, not less. Demand for fast, idiot-proof, needle-free delivery is likely to grow, not shrink.

The market cap is extremely low for a company with this level of government involvement and this level of progress toward approval.
The upside is very large.
The downside is limited.
It is the type of company a bigger player might easily buy out once the regulatory picture clarifies.

Yes there have been delays. Anyone who has ever touched a regulated industry knows these things happen, especially in medtech and anything involving governments or defence. Nothing here looks abnormal to me.

A quick comment to the community. I noticed a lot of negativity and very little coordinated effort. Crossject has almost no visibility outside France and that can only change if the people who care about the stock actually start giving it oxygen. Translate news. Write in English. Share the story. Build awareness. Complaining does nothing.

I am here because the risk reward is great and because I believe the technology will matter in the real world.

Looking forward to the discussions.

Btw I also offered my x handle for free to Crossject team but didn't get any response.

uchimata

17 novembre 2025 •21:21

Thanks for immediately raising the level of this forum by a few notches. :-)

OFredO66

17 novembre 2025 •21:34

crossjectwhale Hello guy and welcome on this drama-forum. I've been a little upset when seeing your X account. I was quite sceptic when I saw your position ;-) but looks like you have a deep knwoledge on the matter. Actually, invested since 7 years on this auction, first time we see an american on this forum :-)
Sign of gratefull days to come? Sorry for my english, don't expect by the way any response from PA, he graps only a few words of English, having difficulty to communicate in french also 😁